Vaxxas, Inc. products

Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines. The core of Vaxxas technology platform is a High Density Microarray Patch (HD-MAP). Vaxxas` HD-MAP is readily fabricated by injection molding to produce small patches each with thousands of very short (~0.25mm) microprojections. Vaxxas has developed novel technologies that enable vaccines to be applied to the tips of the microprojections under sterile conditions. The HD-MAP delivers the vaccine on its microprojections efficiently to the high density populations of immune cells directly beneath the surface of the skin. The microprojections also trigger natural immuno-cellular alarms that cause vaccine components to be rapidly trafficked to lymph nodes eliciting a robust immune response.